Study Links Prenatal Cannabis Exposure To Schizophrenia – New Telegraph

WHY IT MATTERS: Pregnant individuals using cannabis for nausea, anxiety, or pain should know that emerging placental research suggests potential long-term psychiatric risks to their child that current safety guidelines may still be underestimating. CLINICAL OVERVIEW: Emerging research suggests that prenatal cannabis exposure may leave measurable biological signatures in placental tissue that are associated with increased schizophrenia risk in offspring. The placenta acts as a dynamic interface between maternal and fetal environments, and cannabinoids can cross this barrier and influence fetal neurodevelopment during critical windows of brain formation.

Read More

Placental Changes From Prenatal Cannabis Exposure Could Flag Higher Schizophrenia …

WHY IT MATTERS: Pregnant patients who have used cannabis, even early in pregnancy, may want to discuss this emerging research with their obstetric and psychiatric care teams when considering their child’s long-term neurodevelopmental monitoring. CLINICAL OVERVIEW: Emerging research suggests that prenatal cannabis exposure may produce measurable epigenetic and gene expression changes in placental tissue, particularly in pathways associated with neurodevelopmental risk including schizophrenia. The placenta, long underappreciated as a window into fetal programming, appears to reflect cannabis-related disruptions that could correlate with altered brain development trajectories in offspring.

Read More

Indiana lawmakers miss deadline, killing key cannabis bill | News | wthitv.com

WHY IT MATTERS: Indiana patients seeking legal access to cannabis for medical purposes will continue to face criminal and legal barriers, with no near-term legislative relief in sight. CLINICAL OVERVIEW: Indiana legislators allowed a key cannabis reform bill to die by missing a procedural deadline, leaving the state without updated cannabis policy at a time when surrounding states continue to expand patient access. The failure reflects a broader pattern in politically cautious states where cannabis reform stalls not through direct opposition but through inaction and procedural delays.

Read More

Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure

WHY IT MATTERS: If you are pregnant or planning to become pregnant and currently use cannabis, this research underscores why having an honest, judgment-free conversation with your physician about timing, risks, and alternatives is essential for both your care and your baby’s long-term neurodevelopmental health. CLINICAL OVERVIEW: Emerging research is exploring how prenatal cannabis exposure may alter genetic markers in the placenta, particularly in pregnancies associated with low birth weight, and whether those placental changes could serve as early indicators of neurodevelopmental risk including schizophrenia. This builds on what we already know clinically about the endocannabinoid system’s critical role in fetal brain development and placental function.

Read More